Announcements Trials
Browse Landscape

Status

Recruiting 4Active not recruiting 4Completed 3

Sponsor Class

INDUSTRY 10OTHER 1

Study Type

Interventional 81Observational 11Expanded_access 1

Sponsor

Cancer Type

Breast 11Classical hematology 1

Conditions

Breast Neoplasms 10Venous Thromboembolism 1HR+HER2- Advanced Breast Cancer 1Cardiovascular Diseases 1

Interventions

Blood Specimen Collection 135Surveys and Questionnaires 132Specimen Handling 57Observation 55Radiotherapy 43Interviews as Topic 35Surgical Procedures, Operative 31Biopsy 30Drug Therapy 30Data Collection 25Magnetic Resonance Spectroscopy 25Nivolumab 21Immune Checkpoint Inhibitors 18Watchful Waiting 18Standard of Care 17Therapeutics 17Immunotherapy 16Magnetic Resonance Imaging 16trastuzumab deruxtecan 14Liquid Biopsy 13Restraint, Physical 13Tomography, X-Ray Computed 13palbociclib 13Radiosurgery 12enzalutamide 12Focus Groups 11Hematologic Tests 11apalutamide 11darolutamide 11pembrolizumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

11 trials
RecentStart dateEnrollment
Observational × ribociclib × 1 year × Clear all
NCT06930859 2026-05-22

ELEGANCE

Novartis

Recruiting
2,766 enrolled
Breast

Breast Neoplasms

NCT06830720 2026-05-08

CAROLEEN

Novartis

Recruiting
3,250 enrolled
Breast

Breast Neoplasms

NCT06075758 2026-05-06

A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer

Novartis

Completed
175 enrolled
Breast

Breast Neoplasms

NCT06905301 2026-05-05

IMPULSE

Novartis

Recruiting
240 enrolled
Breast

Breast Neoplasms

NCT04943497 2026-04-01

PROSPERITY

Novartis

Completed
2,424 enrolled
Breast

Breast Neoplasms

NCT05697146 2026-03-16

RosaLEE

Novartis

Active not recruiting
1,019 enrolled
Breast

Breast Neoplasms

NCT06797531 2026-02-04

NISLEESA

Novartis

Recruiting
177 enrolled
Breast

Breast Neoplasms

NCT06148506 2025-12-05

ValerEE

Novartis

Active not recruiting
376 enrolled
Breast

HR+HER2- Advanced Breast Cancer

NCT06495164 2025-11-25

A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer

Pfizer

Active not recruiting
1 enrolled
Breast

Breast Neoplasms

NCT07072013 2025-07-18

IRINA

Novartis

Completed
1,937 enrolled
Breast

Breast Neoplasms

NCT07008508 2025-06-06

BRAVE-Cyclin

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Active not recruiting
300 enrolled
BreastClassical hematology

Breast Neoplasms, Cardiovascular Diseases, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡